Status | Study |
Recruiting |
Study Name: Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies Condition: SCID Omenn's Syndrome Reticular Dysgenesis Date: 2012-07-25 Interventions: Drug: Alemtuzumab 0.3 mg 0.3 m |
Completed |
Study Name: Stem Cell Transplant for Immunologic or Histiocytic Disorders Condition: Hemophagocytic Lymphohistiocytosis X-Linked Lymphoproliferative Disorders Date: 2005-09-12 Interventions: Procedure: Stem Cell Transplant |
Completed |
Study Name: T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders Condition: Hemophagocytic Lymphohistiocytosis X-Linked Lymphoproliferative Disorders Date: 2005-09-12 Interventions: Procedure: Stem Cell Transplant |
Completed |
Study Name: Study of Megakaryocytes From Patients With Abnormal Platelet Vesicles Condition: Blood Coagulation Disorders Date: 2004-07-01 |